Immunome, Inc. (IMNM)

Import this data to Google Sheets with:

=jivedata("IMNM","financials")

Full statements spill as a table. For one cell: =jivedata("IMNM","Revenue") or =jivedata("IMNM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Immunome, Inc.

IMNM • CIK 0001472012

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$14,018	$9,041	$6,941	$0
Operating Expenses	$123,548	$314,841	$231,054	$270,465
Research and Development Expense	$23,089	$129,542	$177,286	$206,229
Operating Income (Loss)	$-109,530	$-305,800	$-224,113	$-270,465
Interest Income (Expense), Net	$2,724	$12,837	$11,719	$16,142
Income Tax Expense (Benefit)	$0	$0	$0	$0
Net Income (Loss) Attributable to Parent	$-106,806	$-292,963	$-212,394	$-254,323

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$148,540	$240,241	$683,188	$565,384
Liabilities	$28,658	$59,076	$48,845	$40,301
Assets, Current	$144,703	$221,339	$660,777	$538,449
Cash and Cash Equivalents, at Carrying Value	$98,679	$143,351	$653,482	$217,706
Property, Plant and Equipment, Net	$2,073	$10,113	$14,636	$17,359
Operating Lease, Right-of-Use Asset	$1,564	$4,278	$2,978	$3,942
Deferred Tax Assets, Net of Valuation Allowance	$378	$1,033	$801	$801
Other Assets, Noncurrent	$100	$4,411	$4,587	$5,424
Liabilities, Current	$21,829	$54,307	$44,990	$35,713
Accounts Payable, Current	$3,311	$14,189	$3,339	$5,996
Stockholders' Equity Attributable to Parent	$119,882	$181,165	$634,343	$525,083

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Cash Provided by (Used in) Operating Activities	$-7,568	$-110,794	$-190,919	$-208,793
Net Cash Provided by (Used in) Investing Activities	$-30,484	$-85,063	$60,803	$-196,484
Net Cash Provided by (Used in) Financing Activities	$116,408	$240,529	$640,357	$479,107
Depreciation, Depletion and Amortization	$457	$1,567	$2,466	$2,778
Payments to Acquire Property, Plant, and Equipment	$831	$7,173	$9,685	$10,293
Proceeds from Issuance of Common Stock	$34	$20,000	$45,897	$45,897

Jive Data

Google Sheets add-onSheets Account

Import this data to Google Sheets with:

=jivedata("IMNM","financials")

Full statements spill as a table. For one cell: =jivedata("IMNM","Revenue") or =jivedata("IMNM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Immunome, Inc.

IMNM • CIK 0001472012

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$14,018	$9,041	$6,941	$0
Operating Expenses	$123,548	$314,841	$231,054	$270,465
Research and Development Expense	$23,089	$129,542	$177,286	$206,229
Operating Income (Loss)	$-109,530	$-305,800	$-224,113	$-270,465
Interest Income (Expense), Net	$2,724	$12,837	$11,719	$16,142
Income Tax Expense (Benefit)	$0	$0	$0	$0
Net Income (Loss) Attributable to Parent	$-106,806	$-292,963	$-212,394	$-254,323

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$148,540	$240,241	$683,188	$565,384
Liabilities	$28,658	$59,076	$48,845	$40,301
Assets, Current	$144,703	$221,339	$660,777	$538,449
Cash and Cash Equivalents, at Carrying Value	$98,679	$143,351	$653,482	$217,706
Property, Plant and Equipment, Net	$2,073	$10,113	$14,636	$17,359
Operating Lease, Right-of-Use Asset	$1,564	$4,278	$2,978	$3,942
Deferred Tax Assets, Net of Valuation Allowance	$378	$1,033	$801	$801
Other Assets, Noncurrent	$100	$4,411	$4,587	$5,424
Liabilities, Current	$21,829	$54,307	$44,990	$35,713
Accounts Payable, Current	$3,311	$14,189	$3,339	$5,996
Stockholders' Equity Attributable to Parent	$119,882	$181,165	$634,343	$525,083

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Cash Provided by (Used in) Operating Activities	$-7,568	$-110,794	$-190,919	$-208,793
Net Cash Provided by (Used in) Investing Activities	$-30,484	$-85,063	$60,803	$-196,484
Net Cash Provided by (Used in) Financing Activities	$116,408	$240,529	$640,357	$479,107
Depreciation, Depletion and Amortization	$457	$1,567	$2,466	$2,778
Payments to Acquire Property, Plant, and Equipment	$831	$7,173	$9,685	$10,293
Proceeds from Issuance of Common Stock	$34	$20,000	$45,897	$45,897

Immunome, Inc.

Consolidated Statements of Operations

Consolidated Balance Sheets

Consolidated Statements of Cash Flows

Immunome, Inc.

Consolidated Statements of Operations

Consolidated Balance Sheets

Consolidated Statements of Cash Flows